
Infinitas Capital
Description
Infinitas Capital is a single family office based in Basel, Switzerland, founded by Peter and Robin Lauber. The firm operates with a dual focus on residential real estate developments and early-stage venture capital investments. In its venture capital arm, Infinitas Capital primarily targets technology companies across Europe, with a specific emphasis on markets such as Switzerland, Germany, Austria, and the UK. The firm positions itself as a long-term oriented partner, actively supporting founders and management teams to scale disruptive business models.
The investment strategy of Infinitas Capital for its venture capital portfolio is centered on Seed to Series A rounds. The firm is sector-agnostic but has demonstrated a particular interest in emerging areas like FinTech, Software-as-a-Service (SaaS), DeepTech, and ClimateTech. Infinitas Capital's initial cheque size typically ranges from CHF 250,000 to CHF 1,500,000, which translates to approximately USD 280,000 to USD 1,680,000 based on recent exchange rates. This range allows them to participate meaningfully in early-stage funding rounds while also leaving room for potential follow-on investments as their portfolio companies grow.
Infinitas Capital has built a diverse portfolio of promising European startups. Their investment track record includes notable companies such as Planted, a food technology firm; Yokoy, an AI-powered spend management solution; and Ledgy, an equity management platform. With over a dozen known investments to date, the family office demonstrates a consistent commitment to fostering innovation within the European tech ecosystem. Their hands-on approach and strategic capital aim to empower companies with strong management teams and scalable solutions.
Investor Profile
Infinitas Capital has backed more than 21 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 5% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Seed rounds (top funding stages).
- Majority of deals are located in Germany, United States, Switzerland.
- Strong thematic focus on Biotechnology, Life Science, Health Care.
- Typical check size: $280K – $1.7M.
Stage Focus
- Series B (24%)
- Series A (24%)
- Seed (19%)
- Series C (10%)
- Series Unknown (10%)
- Pre Seed (10%)
- Series D (5%)
Country Focus
- Germany (43%)
- United States (33%)
- Switzerland (10%)
- Cayman Islands (5%)
- Mexico (5%)
- United Kingdom (5%)
Industry Focus
- Biotechnology
- Life Science
- Health Care
- Therapeutics
- Mental Health
- Biopharma
- Medical
- E-commerce
- Real Estate
- Financial Services
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.